Verve Therapeutics, Inc. (VERV) Tops Q1 EPS by 30c
Tweet
Share
E-mailGet Alerts VERV Hot Sheet
Join SI Premium – FREE
Verve Therapeutics, Inc. (NASDAQ: VERV) reported Q1 EPS of ($0.35), $0.30 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $32.98 million versus the consensus estimate of $7.88 million.
For earnings history and earnings-related data on Verve Therapeutics, Inc. (VERV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
